Last quarter (Q4 2023), Mirum Pharmaceuticals's total revenue was $69.55M, an increase of Infinity% from the same quarter last year. In Q4, Mirum Pharmaceuticals's net income was $25.58M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 178.87M	$ 186.37M	$ 77.06M	$ 19.14M	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	$ 0.00	-
Gross Profit	$ 117.28M	$ 186.37M	$ 77.06M	$ 19.14M	$ 0.00	-
Operating Expense	$ 295.53M	$ 295.53M	$ 208.28M	$ -192.55M	$ 104.30M	$ 54.74M
Operating Income	$ -164.63M	$ -109.15M	$ -131.22M	$ -174.15M	$ -104.30M	$ -54.74M
Net Non Operating Interest Income Expense	$ 9.49M	$ 13.73M	$ 3.86M	$ -17.22M	$ 1.22M	$ 2.23M
Other Income Expense	$ 51.90M	$ 51.90M	$ -365.00K	$ 582.00K	$ -192.00K	$ -21.00K
Pretax Income	$ -162.42M	$ -162.42M	$ -142.07M	$ -83.95M	$ -103.26M	$ -52.53M
Tax Provision	$ 991.00K	$ 991.00K	$ -6.41M	$ 37.00K	$ 6.00K	$ 21.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -157.47M	$ -163.41M	$ -94.94M	$ -83.99M	$ -103.27M	$ -52.55M
Basic EPS	$ -4.07	$ -4.00	$ -4.01	$ -2.77	$ -4.09	$ -4.58
Diluted EPS	$ -4.07	$ -4.00	$ -4.02	$ -2.77	$ -4.09	$ -4.58
Basic Average Shares	$ 163.54M	$ 40.89M	$ 33.84M	$ 30.32M	$ 25.25M	$ 11.49M
Diluted Average Shares	$ 163.54M	$ 40.89M	$ 33.98M	$ 30.32M	$ 25.25M	$ 11.49M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 295.53M	$ 295.53M	$ 208.28M	$ -192.55M	$ 104.30M	$ 54.74M
Net Income From Continuing And Discontinued Operation	$ -163.41M	$ -163.41M	$ -135.66M	$ -83.99M	$ -103.27M	$ -52.55M
Normalized Income	$ -104.67M	$ -128.31M	$ -148.48M	-	$ -103.27M	$ -52.55M
Interest Expense	-	-	-	-	$ 335.00K	$ 0.00
EBIT	$ -158.18M	$ -162.42M	$ -142.07M	$ -66.36M	$ -102.93M	$ -52.53M
EBITDA	$ -127.46M	$ -152.20M	$ -140.09M	$ -65.52M	$ -102.31M	$ -52.21M

Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing